A pilot study of bevacizumab combined with etoposide and cisplatin in breast cancer patients with leptomeningeal carcinomatosis

BACKGROUND: Elevated vascular endothelial growth factor (VEGF) was associated with poor prognosis in leptomeningeal carcinomatosis and anti-angiogenic therapy was found to prolong the survival of mice in preclinical studies. This prospective pilot study investigated the efficacy of anti-VEGF therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Pei-Fang, Lin, Ching-Hung, Kuo, Ching-Hua, Chen, Wei-Wu, Yeh, Dah-Cherng, Liao, Hsiao-Wei, Huang, Shu-Min, Cheng, Ann-Lii, Lu, Yen-Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403836/
https://www.ncbi.nlm.nih.gov/pubmed/25928457
http://dx.doi.org/10.1186/s12885-015-1290-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403836/
https://www.ncbi.nlm.nih.gov/pubmed/25928457
http://dx.doi.org/10.1186/s12885-015-1290-1

Ejemplares similares